12 Aug 2016
New safety, stability and efficacy studies on LactoSpore
By Staff Writer
Sabinsa’s shelf-stable Bacillus coagulans MTCC 5856, its LactoSpore probiotic, has been extensively researched in the 20 years since it was introduced, and recently several new studies, including clinical studies, have been published. Areas researched include safety and tolerability, shelf life stability, genetic and phenotypic stability, and anti-diarrheal activity, all with positive and significant results.
